Mounjaro (tirzepatide) has generated remarkable before and after results in clinical trials, with patients losing an average of 15 to 22% of their total body weight over 72 weeks — figures that significantly outperform any previously approved weight loss medication and represent a genuine step change in what pharmacological treatment can achieve. In real-world clinical practice, the before and after picture is equally impressive: patients typically begin to notice reduced appetite and fewer food cravings within the first two to four weeks, with meaningful, visible weight loss becoming apparent from around weeks four to eight as the dose increases and lifestyle changes take hold. Beyond the numbers on the scales, Mounjaro before and after results extend to measurable improvements in blood sugar control, blood pressure, cholesterol levels, and a range of weight-related health conditions — making it a genuinely transformative treatment for eligible patients rather than simply a weight loss tool. Results vary between individuals depending on starting weight, dose, adherence, and the lifestyle changes made alongside treatment, and it is important to approach Mounjaro with realistic expectations and proper clinical supervision rather than expecting overnight transformation. At Newington Pharmacy in Edinburgh, our experienced team supports patients throughout their Mounjaro journey — from initial assessment and prescription to ongoing monitoring and guidance — to help you achieve the best possible results safely and sustainably.
Book now
Before the before and after journey begins, a thorough clinical assessment is essential to ensure Mounjaro is both appropriate and safe for your individual circumstances. A qualified prescriber will review your medical history, current medications, BMI, and any weight-related health conditions to confirm eligibility. In the UK, Mounjaro for weight management is currently licensed for adults with a BMI of 35 or above alongside at least one weight-related co-morbidity, or a BMI of 30 to 34.9 with at least one weight-related co-morbidity in certain clinical circumstances — eligibility should always be confirmed with your prescriber as criteria may vary between providers. Your prescriber will also discuss what realistic expectations look like for you specifically, based on your starting weight and health profile, and will outline the dose escalation schedule, potential side effects, and the lifestyle changes that will maximise your results. This preparation phase is not a formality — it is the foundation on which a successful Mounjaro journey is built.
A clear picture of what to expect as your treatment progresses makes it significantly easier to stay on track during the early adjustment period and maintain the kind of realistic outlook that leads to long-term success.
Early Appetite Changes (Wk 1 – 4) — Most patients begin to notice reduced appetite, earlier feelings of fullness, and fewer food cravings within the first one to four weeks. The starting dose of 2.5mg is a sub-therapeutic initiation dose used to support tolerability — weight loss at this stage is minimal and is not the primary goal. Some patients experience nausea, fatigue, or mild gastrointestinal symptoms during this adjustment period.
Visible Progress Begins (Wk 5 – 12) — As the dose increases to 5mg and beyond, appetite suppression becomes more pronounced and consistent weight loss becomes more apparent. Most patients lose between two and four kilograms per month during this phase when combining treatment with dietary changes and regular activity. Energy levels often begin to improve as weight comes off and metabolic function improves.
Significant Transformation (Mo 3 – 6) — This is the phase in which the most dramatic before and after changes typically become visible. With doses reaching 7.5mg to 10mg, many patients report significant changes in clothing size, body shape, energy, mobility, and overall wellbeing. Blood sugar, blood pressure, and cholesterol improvements are often measurable at this stage and may prompt a review of other medications.
Maximum Results and Consolidation (Mo 16 – 18) — Clinical trial data shows that the greatest total weight loss is achieved between months six and eighteen, as doses reach their maximum level and the cumulative effect of sustained lifestyle changes takes hold. Patients on the highest dose of 15mg in the SURMOUNT-1 trial achieved an average weight loss of 22.5% of total body weight — equivalent to over 20kg for many participants. This phase is also where long-term habit formation becomes critical for maintaining results.

One of the most significant aspects of the Mounjaro before and after story is that its benefits extend well beyond the number on the scales. Clinical trial data consistently shows that tirzepatide produces meaningful improvements across a wide range of metabolic and cardiovascular health markers — changes that can have a profound impact on long-term health outcomes and quality of life. Patients with type 2 diabetes see significant reductions in HbA1c (a measure of average blood sugar over three months), frequently to the extent that their diabetes medications require review and reduction. Blood pressure improvements are commonly reported, as are reductions in triglycerides and improvements in HDL cholesterol. Patients living with the daily burden of obesity-related sleep apnoea, joint pain, or reduced mobility often find that the functional improvements of sleeping better, moving more freely, and experiencing less pain make a more profound difference to their lives than the weight loss figures themselves.
To give you a clear and evidence-based picture of what Mounjaro can realistically achieve at each dose, the table below summarises the average weight loss outcomes recorded across each dose level in the landmark SURMOUNT-1 clinical trial.
| Dose | Avg. Weight Loss (% Body Weight) | Avg. Weight Loss (kg)* | Timeframe |
|---|---|---|---|
| 2.5mg (starting dose) | Sub-therapeutic initiation dose — weight loss at this stage is minimal and not the primary goal | Weeks 1–4 | |
| 5mg | Approx. 5–8% | 4–7kg | Weeks 5–8 |
| 7.5mg | Approx. 10–13% | 8–12kg | Months 3–4 |
| 10mg | Approx. 13–17% | 11–15kg | Months 4–6 |
| 12.5mg | Approx. 17–20% | 14–18kg | Months 6–12 |
| 15mg (maximum dose) | Approx. 20–22.5% | 17–22kg+ | Months 9–18 |
*Based on average starting weight of approximately 100–105kg from SURMOUNT-1 trial data. Individual results will vary. Cumulative weight loss figures reflect total loss from baseline at each dose stage, not incremental loss per dose.
From your first consultation to your most significant milestones, Newington Pharmacy in Edinburgh provides personalised Mounjaro prescribing and ongoing clinical support designed to give you the best possible foundation for long-term success. Contact us to explore our Mounjaro treatment.
While the clinical trial data for Mounjaro is impressive, it is important to understand that individual results vary — sometimes considerably — depending on a range of factors that are both within and outside your control. Starting weight is one of the most significant variables: patients with a higher initial BMI tend to lose more weight in absolute terms, though percentage body weight loss is more consistent across the range. Dose reached is directly linked to outcomes — patients who tolerate and reach the higher doses of 12.5mg and 15mg consistently achieve greater results than those who remain on lower doses due to side effects or tolerability issues. Lifestyle factors — particularly dietary quality and physical activity — play a genuinely substantial role in determining how far above or below the clinical trial averages an individual patient lands. Consistency and adherence matter enormously: missing doses, irregular injection scheduling, or stopping and restarting treatment all negatively affect outcomes.
If you want to understand how these factors apply to your individual circumstances, call us to book a consultation with our experienced team at Newington Pharmacy in Edinburgh and let us help you build a plan that gives you the best possible chance of achieving your goals.

Whether you are just starting to explore Mounjaro or are already several weeks into your treatment, here are honest answers to the questions about before and after results that our Edinburgh team hears most often.
Most patients begin to notice reduced appetite and fewer food cravings within the first one to four weeks of starting Mounjaro, though visible weight loss typically becomes more apparent from weeks four to eight as the dose increases beyond the initiation phase and lifestyle changes take effect. The most significant and dramatic results are generally seen from month three onwards as doses reach the mid-to-upper range of the escalation schedule.
Clinical trial data from the SURMOUNT-1 study shows average weight loss of 15 to 22.5% of total body weight over 72 weeks depending on the dose reached, which equates to approximately 15 to 22kg for a patient with a starting weight of around 100kg. Individual results vary considerably depending on starting weight, dose tolerance, and lifestyle factors — speaking with your prescriber about realistic personal expectations is always recommended before starting treatment.
The clinical evidence is clear that stopping Mounjaro without maintaining the lifestyle changes made during treatment significantly increases the risk of weight regain, as the appetite-suppressing effects of the medication do not persist once injections cease. This underscores the importance of using the treatment period to embed sustainable dietary and activity habits that can support weight maintenance independently of the medication over the long term.
The SURMOUNT-5 trial, which directly compared tirzepatide with semaglutide 2.4mg, showed greater average weight loss with Mounjaro — making it the strongest available head-to-head evidence for its comparative effectiveness against other GLP-1 weight loss medications. That said, the most appropriate medication for any individual patient depends on their specific health profile, tolerability, and clinical circumstances rather than trial averages alone.
According to both clinical guidelines and trial data, the best Mounjaro before and after results are seen in patients who pair their treatment with a reduced-calorie, nutrient-dense diet and a minimum of 150 minutes of moderate-intensity physical activity each week. Strength or resistance training is particularly valuable as it preserves muscle mass during weight loss, which helps maintain a higher metabolic rate and supports better long-term weight maintenance.
Yes — at Newington Pharmacy in Edinburgh, our experienced team offers private Mounjaro prescribing with a full clinical assessment, personalised dose management, and ongoing support throughout your treatment journey. No GP referral is required, and most patients can complete their initial assessment and begin treatment within a matter of days.
The Mounjaro before and after story is one of the most compelling in modern weight management medicine — supported by robust clinical evidence, meaningful health improvements beyond weight loss alone, and patient experiences that are genuinely transformative for those who are eligible and committed to making the most of their treatment. The key is approaching it with both optimism and realism: understanding what the evidence shows, setting personalised expectations with your prescriber, and committing to the lifestyle changes that will amplify and sustain your results long after the last injection.
At Newington Pharmacy in Edinburgh, our experienced team is here to support you through every stage of your Mounjaro journey — from your first consultation to your most significant milestones. If you are ready to find out whether Mounjaro is right for you, we are ready to help you take that first important step. The evidence is compelling, the support is in place, and the team is ready. Book your Mounjaro consultation at Newington Pharmacy in Edinburgh today and let us help you write your own before and after story.
